Setting the Standard Since 1971
Cart 0

Injectable Drug Compatibility News

2024 Y-Site Compatibility Wall Charts

We are pleased to announce the launch of our new 2024 Y-Site Compatibility Wall Charts. Ideal for situations where a quick 'yes' or 'no answer is required prior to administration of intravenous drugs.You can easily check if two drugs can be mixed in the same infusion line (Y-site) without causing precipitation, degradation, or inactivation. You can also see which infusion fluids are compatible with each drug, and if there are any FDA Boxed Warning Drugs that require special attention. Updated for 2024 with the latest information from the King Guide to Parenteral Admixtures, a trusted source of intravenous drug compatibility...

Read more →


Winter 2023

In this update to the King Guide to Parenteral Admixtures we added a new monograph for SULBACTAM AND DURLOBACTAM. We also added new stability information to the monographs for OMADACYCLINE. New compatibility information was added for SULBACTAM AND DURLOBACTAM in combination with 95 different drugs.

Read more →


Fall 2023

In this update we added a new monograph for NUTRILIPID. We also added new stability information to the monographs for FAT EMULSION, NUTRILIPID, NOREPINEPHRINE BITARTRATE and TRACE ELEMENT SOLUTION. New compatibility information was added to the existing drug monographs for FAT EMULSION with 36 different drugs; INTRALIPID, NUTRILIPID, and SMOFLIPID, each with 17 different drugs; TOTAL PARENTERAL NUTRITION SOLUTIONS, TRACE ELEMENT SOLUTION, and VALPROATE SODIUM.

Read more →


Summer 2023

In this update we added new monographs for MOGAMULIZUMAB-KPKC and REMIMAZOLAM BESYLATE. We also added new stability information to the monographs for ASPARAGINASE, BEVACIZUMAB, DEXCHLORPHENIRAMINE MALEATE, FERRIC CARBOXYMALTOSE, IDARUBICIN HYDROCHLORIDE, ISOPROTERENOL HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE, VASOPRESSIN, and VORICONAZOLE. New compatibility information was added to the existing drug monographs for CALCIUM CHLORIDE, DEFIBROTIDE SODIUM, DEXMEDETOMIDINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, REMIFENTANIL HYDROCHLORIDE, and REMIMAZOLAM BESYLATE with six other drugs.

Read more →


New IV Compatibility for Spring 2023

Spring 2023 In this update we added a new monograph for LACOSAMIDE. We also added new stability information to the monographs for ASCORBIC ACID, CONJUGATED ESTROGENS, LEVOLEUCOVORIN CALCIUM, SODIUM BICARBONATE, and THIAMINE HYDROCHLORIDE. New compatibility information was added to the existing drug monographs for CYTARABINE, DEXAMETHASONE SODIUM PHOSPHATE, METHOTREXATE, METHYLPREDNISOLONE SODIUM SUCCINATE, ONDANSETRON HYDROCHLORIDE, and DEXMEDETOMIDINE with twenty-three other drugs.

Read more →